Charles Cowey is an Oncology physician. OpenAlex indexes 34 publications with 328 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3410 Worth St
Dallas, TX 752462003
Telephone
214-370-1000Provider last certified this registry record 26 Oct 2023.
Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20253 payments
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- Tempus AI, IncProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
59.9%PD-1 inhibitor41.3%Pembrolizumab63%Nivolumab37%Part B, office-administered≥41 patientsPlatinum-based Drug9.6%Oxaliplatin98%Carboplatin3%Part B, office-administered≥22 patients+ 10 more classes in this area
Metabolism & gastrointestinal
23.7%Other antiemetics19.5%Fosaprepitant100%Part B, office-administered≥59 patientsSerotonin-3 Receptor Antagonist2.7%Palonosetron hcl62%Granisetron hydrochloride37%Ondansetron Odt1%Part D + Part B<11 patients+ 4 more classes in this area
Musculoskeletal
12.4%RANK Ligand Inhibitor12.3%Denosumab100%Part B, office-administered≥19 patientsBisphosphonate0.1%Zoledronic acid100%Part B, office-administered≥18 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”